{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:16:17Z","timestamp":1788318977227,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2023-06-60"],"award-info":[{"award-number":["320.6750.2023-06-60"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2024-NHLHCRF-PY\u2160-09 and 2023-NHLHCRF-PY-04"],"award-info":[{"award-number":["2024-NHLHCRF-PY\u2160-09 and 2023-NHLHCRF-PY-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The uric acid to high-density lipoprotein cholesterol ratio (UHR), a novel biomarker, has clinical value in diagnosing and evaluating metabolic syndrome, diabetes mellitus, and atherosclerosis. However, the relationship between UHR and mortality in gout patients is unknown.This study aimed to investigate UHR\u2019s link to all-cause and cardiovascular mortality in gout patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on NHANES data from 2007 to 2018, 1,479 gout patients who completed follow-up as of December 31, 2018 were included, and patients were divided into four groups using UHR, we analyzed the relationship between UHR and risk of death using Cox regression models, tested for nonlinear relationships with a restricted cubic spline, and assessed for population heterogeneity by stratifying by sex, age, and body mass index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The Kaplan-Meier analysis revealed that patients in the third UHR quartile (Q3) had the highest risk of death. The multivariate Cox regression analysis further confirmed that the overall mortality risk (HR: 1.44, 95% CI: 1.05\u20131.97) and cardiovascular mortality risk (HR: 1.73, 95% CI: 1.04\u20132.87) of this group were higher than those of the other groups. Restricted cubic spline analysis revealed a U-shaped association between UHR and all-cause mortality, with a significant positive correlation above a threshold of 21.6% (HR: 1.68, 95% CI: 1.26\u20132.24) and a linear positive correlation with cardiovascular mortality (HR: 1.40, 95% CI: 1.05\u20131.86). Subgroup analyses showed that these associations were consistent across age, BMI, and sex (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05 for interaction).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study confirms that UHR in gout patients has a U-shaped correlation with all-cause mortality and a linear correlation with cardiovascular mortality. Therefore, UHR may serve as a novel prognostic biomarker for mortality risk stratification in patients with gout.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-025-05254-x","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:16:23Z","timestamp":1763547383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause mortality and cardiovascular disease mortality in patients with gout"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaolin","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"7","key":"5254_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM, American college of Physicians, American physiological Society. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499\u2013516.","journal-title":"Ann Intern Med"},{"issue":"10","key":"5254_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1301\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"5254_CR3","first-page":"ii2","volume":"48","author":"M Doherty","year":"2009","unstructured":"Doherty M. New insights into the epidemiology of gout. Rheumatol (Oxf Engl). 2009;48(Suppl 2):ii2\u20138.","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"17","key":"5254_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"5254_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","volume":"24","author":"EUR Smith","year":"2010","unstructured":"Smith EUR, D\u00edaz-Torn\u00e9 C, Perez-Ruiz F, et al. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol. 2010;24(6):811\u201327.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"5254_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1751-7176.2010.00406.x","volume":"13","author":"RD Brook","year":"2011","unstructured":"Brook RD, Yalavarthi S, Myles JD, et al. Determinants of vascular function in patients with chronic gout. J Clin Hypertens Greenwich Conn. 2011;13(3):178\u201388.","journal-title":"J Clin Hypertens Greenwich Conn"},{"issue":"3","key":"5254_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00325481.2022.2039007","volume":"134","author":"G Aktas","year":"2022","unstructured":"Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297\u2013302.","journal-title":"Postgrad Med"},{"key":"5254_CR8","doi-asserted-by":"crossref","unstructured":"Lim S, Shen et al. Association of variability in uric acid and future clinical outcomes of patients with coronary artery disease undergoing percutaneous coronary intervention. Atherosclerosis. 2020; 297: 40\u201346.","DOI":"10.1016\/j.atherosclerosis.2020.01.025"},{"issue":"9","key":"5254_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-013-0400-4","volume":"15","author":"FK Welty","year":"2013","unstructured":"Welty FK. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep. 2013;15(9):400.","journal-title":"Curr Cardiol Rep"},{"key":"5254_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1567-5688(17)30021-1","volume":"26","author":"M Averna","year":"2017","unstructured":"Averna M, Stroes E. How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL. Atheroscler Suppl. 2017;26:16\u201324.","journal-title":"Atheroscler Suppl"},{"key":"5254_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108615","volume":"256","author":"S Wen","year":"2024","unstructured":"Wen S, Arakawa H, Tamai I. Uric acid in health and disease: from physiological functions to pathogenic mechanisms. Pharmacol Ther. 2024;256:108615.","journal-title":"Pharmacol Ther"},{"issue":"12","key":"5254_CR12","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.3390\/ijms23126786","volume":"23","author":"G Mocciaro","year":"2022","unstructured":"Mocciaro G, D\u2019Amore S, Jenkins B, et al. Lipidomic approaches to study HDL metabolism in patients with central obesity diagnosed with metabolic syndrome. Int J Mol Sci. 2022;23(12):6786.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"5254_CR13","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1042\/CS20190873","volume":"133","author":"N Hui","year":"2019","unstructured":"Hui N, Barter PJ, Ong KL, et al. Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL. Clin Sci. 2019;133(21):2221\u201335.","journal-title":"Clin Sci"},{"key":"5254_CR14","doi-asserted-by":"crossref","unstructured":"Yang Y, Shen XY, Tang HX et al. Sex differences in the association of the uric acid to high-density lipoprotein cholesterol ratio with coronary artery disease risk among Chinese nondialysis patients with CKD stages 3\u20135. Nutr metab cardiovasc dis: NMCD. 2024; 34 (6): 1546\u201353.","DOI":"10.1016\/j.numecd.2024.03.003"},{"issue":"9","key":"5254_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.18087\/cardio.2021.9.n1750","volume":"61","author":"C Ayd\u0131n","year":"2021","unstructured":"Ayd\u0131n C, Emlek N. The relationship between uric acid to high-density lipoprotein cholesterol ratio and collateral index in patients with chronic total occlusion. Kardiologiia. 2021;61(9):61\u20135.","journal-title":"Kardiologiia"},{"issue":"4","key":"5254_CR16","first-page":"403","volume":"59","author":"O Kurtkulagi","year":"2021","unstructured":"Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto\u2019s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59(4):403\u20138.","journal-title":"Rom J Intern Med"},{"key":"5254_CR17","doi-asserted-by":"crossref","unstructured":"Kosekli MA, Kurtkulagii O, Kahveci G et al. The association between serum uric acid and high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021; 67 (4): 549\u2013554.","DOI":"10.1590\/1806-9282.20201005"},{"issue":"1","key":"5254_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/1806-9282.65.1.9","volume":"65","author":"MZ Kocak","year":"2019","unstructured":"Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9\u201315.","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"1","key":"5254_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.311","volume":"5","author":"F Yazdi","year":"2022","unstructured":"Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinology, Diabetes & Metabolism. 2022;5(1):e00311.","journal-title":"Endocrinology, Diabetes & Metabolism"},{"issue":"2","key":"5254_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.numecd.2020.10.005","volume":"31","author":"R Liu","year":"2021","unstructured":"Liu R, Peng Y, Wu H, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2021;31(2):561\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"5254_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02521-w","volume":"24","author":"Y Kong","year":"2025","unstructured":"Kong Y, Lin M, Fu Y, Huang B, Jin M, Ma L. Elevated log uric acid-to-high-density lipoprotein cholesterol ratio (UHR) as a predictor of increased female infertility risk: insights from the NHANES 2013\u20132020. Lipids Health Dis. 2025;24(1):127.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"5254_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02551-4","volume":"24","author":"Y Yi","year":"2025","unstructured":"Yi Y, Luo Q, Chen J, et al. Association between the uric acid-to-HDL-cholesterol ratio (UHR) and the risk of cardiovascular disease and dyslipidemia: a population-based study. Lipids Health Dis. 2025;24(1):143.","journal-title":"Lipids Health Dis"},{"issue":"12","key":"5254_CR23","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.numecd.2023.07.037","volume":"33","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhang J, Jia L, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular events in patients with coronary chronic total occlusion. Nutr Metab Cardiovasc Dis. 2023;33(12):2471\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"5254_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50924-4","volume":"9","author":"X Li","year":"2019","unstructured":"Li X, Guan B, Wang Y, et al. Association between high-density lipoprotein cholesterol and all-cause mortality in the general population of Northern China. Sci Rep. 2019;9(1):14426.","journal-title":"Sci Rep"},{"issue":"10","key":"5254_CR25","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.2215\/CJN.00730116","volume":"11","author":"B Bowe","year":"2016","unstructured":"Bowe B, Xie Y, Xian H, et al. High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans. Clin J Am Soc Nephrol. 2016;11(10):1784\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5254_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2017.03.008","volume":"260","author":"O Lamacchia","year":"2017","unstructured":"Lamacchia O, Fontana A, Pacilli A, et al. On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus. Atherosclerosis. 2017;260:20\u20136.","journal-title":"Atherosclerosis"},{"issue":"1","key":"5254_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72527-4","volume":"14","author":"Z Song","year":"2024","unstructured":"Song Z, Deng D, Wu H. Association of serum uric acid to all-cause and cardiovascular mortality in patients with cardiovascular disease. Sci Rep. 2024;14(1):21808.","journal-title":"Sci Rep"},{"issue":"2","key":"5254_CR28","doi-asserted-by":"publisher","first-page":"e001015","DOI":"10.1136\/rmdopen-2019-001015","volume":"5","author":"F P\u00e9rez Ruiz","year":"2019","unstructured":"P\u00e9rez Ruiz F, Richette P, Stack AG, et al. Failure to reach uric acid target of <\u20090.36 mmol\/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality. RMD Open. 2019;5(2):e001015.","journal-title":"RMD Open"},{"issue":"5","key":"5254_CR29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1253\/circj.CJ-14-1267","volume":"79","author":"S Sugihara","year":"2015","unstructured":"Sugihara S, Hisatome I, Kuwabara M, et al. Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J. 2015;79(5):1125\u201332.","journal-title":"Circ J"},{"issue":"6","key":"5254_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061422","volume":"10","author":"B Park","year":"2022","unstructured":"Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans. Biomedicines. 2022;10(6):1422.","journal-title":"Biomedicines"},{"key":"5254_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/DMSO.S387726","volume":"16","author":"Y Xuan","year":"2023","unstructured":"Xuan Y, Zhang W, Wang Y, et al. Association between uric acid to HDL cholesterol ratio and diabetic complications in men and postmenopausal women. Diabetes Metab Syndr Obes: Targets Ther. 2023;16:167\u201377.","journal-title":"Diabetes Metab Syndr Obes: Targets Ther"},{"key":"5254_CR32","doi-asserted-by":"crossref","unstructured":"Yang Y, Shen X, yan, Tang H et al. xia,. Sex differences in the association of the uric acid to high-density lipoprotein cholesterol ratio with coronary artery disease risk among Chinese nondialysis patients with CKD stages 3\u20135. Nutr Metab Cardiovas. 2024; 34 (6): 1546\u20131553.","DOI":"10.1016\/j.numecd.2024.03.003"},{"issue":"2","key":"5254_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.numecd.2020.10.005","volume":"31","author":"R Liu","year":"2021","unstructured":"Liu R, Peng Y, Wu H, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2021;31(2):561\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"5254_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","volume":"103","author":"S Copur","year":"2022","unstructured":"Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. 2022;103:4\u201312.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"5254_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/ATVBAHA.119.313224","volume":"40","author":"Y Kimura","year":"2020","unstructured":"Kimura Y, Yanagida T, Onda A, Tsukui D, Hosoyamada M, Kono H. Soluble uric acid promotes atherosclerosis via AMPK (AMP-activated protein kinase)-mediated inflammation. Arterioscler Thromb Vasc Biol. 2020;40(3):570\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"5254_CR36","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1042\/CS20200892","volume":"134","author":"JD Beazer","year":"2020","unstructured":"Beazer JD, Patanapirunhakit P, Gill JMR, et al. High-density lipoprotein\u2019s vascular protective functions in metabolic and cardiovascular disease - could extracellular vesicles be at play? Clin Sci (Lond). 2020;134(22):2977\u201386.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"5254_CR37","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1016\/j.numecd.2024.07.001","volume":"34","author":"L Ding","year":"2024","unstructured":"Ding L, Guo H, Zhang C, et al. Serum uric acid to high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality in patients with diabetes: evidence from NHANES 2005\u20132018. Nutr Metab Cardiovasc Dis. 2024;34(11):2480\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"5254_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, et al. Contemporary prevalence of gout and hyperuricemia in the united States and decadal trends: the National health and nutrition examination survey, 2007\u20132016. Arthritis Rheumatol. 2019;71(6):991\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"5254_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(62)90501-9","volume":"280","author":"JS Faires","year":"1962","unstructured":"Faires JS, McCarty DJ. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet. 1962;280:682\u20135.","journal-title":"Lancet"},{"issue":"1","key":"5254_CR40","first-page":"65","volume":"40","author":"K Torimoto","year":"2018","unstructured":"Torimoto K, Okada Y, Tanaka Y. [Type 2 diabetes and vascular endothelial Dysfunction]. JUOEH. 2018;40(1):65\u201375.","journal-title":"JUOEH"},{"issue":"18","key":"5254_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100275","volume":"8","author":"S Demir","year":"2021","unstructured":"Demir S, Nawroth PP, Herzig S, et al. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci. 2021;8(18):e2100275.","journal-title":"Adv Sci"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05254-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:16:26Z","timestamp":1763547386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5254"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05254-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Institutional Review Board of the National Health Statistics Centre, and written informed consent was acquired from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. XL and RG contributed equally to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"821"}}